Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,971,135
New position
Shares Held
121,143
first reported quarter
Ownership
0.008%
of shares outstanding
% of Portfolio
1.85%
of 13F equity value
Holder Rank
#216
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GAM Holding AG holds $88,153,297 across 8 Drug Manufacturers - General names. AZN ranks #2 (26.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,843 | $27,398,580 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
121,143 | $22,971,135 | |
| 3 | JNJ |
Johnson & Johnson
|
57,382 | $14,573,306 | |
| 4 | MRK |
Merck & Co., Inc.
|
93,799 | $12,053,171 | |
| 5 | ABBV |
AbbVie Inc.
|
24,717 | $6,219,785 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
50,869 | $2,931,071 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
13,536 | $1,710,138 | |
| 8 | PFE |
Pfizer Inc
|
12,297 | $296,111 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,971,135 | 121,143 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||